MedTrace Logo

Effect of WB-EMS on Parkinson's Disease

NCT04878679 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2023-05-11

No results posted yet for this study

Summary

The aim is to establish adequate and suitable protocols for PD patients and to determine the WB-EMS effects on muscle strength, balance, walking, cognitive functions,neurotrophic factors and alpha-synuclein. Thirty-six PD patients, aged from 50 to 80 years, will be recruited and randomly assigned to two experimental groups (EGs and EGc) and one control group (CG), in order to perform dynamic movements with WB-EMS. EGs will undergo to 12-20 minutes of progressive supervised WB-EMS (4 sec. 85 HZ and 4 sec. rests) combined to light dynamic movements, two-time per week for 12/24 weeks. EGe will undergo to 12-20 minutes of progressive supervised WB-EMS 7 Hz) combined with cardiovascular training with rowing machine. CG will not perform any type of physical activity. Pre and post intervention assessment will be carried out on the following areas: physical assessment, neurocognitive, neurotrophic factors and alpha-synuclein assesments. A 3 months follow-up will be performed.

Conditions

  • Parkinson Disease

Interventions

OTHER

Strenght training combined with WB-EMS

Bodyweight exercise training combined with WB-EMS (2 times/week) with a 85Hz electrical impulse

OTHER

Cardiovascular training with WB-EMS

Cardiovascular training , using the rowing machine, combined with WB-EMS (2 times/week) with a 7Hz electrical impulse

OTHER

Control group

No physical activity

Sponsors & Collaborators

  • Università degli studi di Roma Foro Italico

    lead OTHER

  • Giuseppe Calcagno

    collaborator UNKNOWN

  • Giovanni Fiorilli

    collaborator UNKNOWN

  • Andrea Buonsenso

    collaborator UNKNOWN

  • Marco Centorbi

    collaborator UNKNOWN

Principal Investigators

  • Alessandra di Cagno · Università degli studi di Roma Foro Italico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2022-09-23
Completion
2023-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04878679 on ClinicalTrials.gov